VISTN Vistin Pharma ASA

Vistin Pharma ASA: Mandatory notification of trade

Vistin Pharma ASA: Mandatory notification of trade

Ferncliff Listed DAI AS has on 30 May 2023 purchased 250,000 shares in Vistin Pharma ASA at NOK 23.12 per share.

After the transaction Ferncliff Listed DAI AS has a holding of 1,034,280 shares, corresponding to 2,33% ownership. Ferncliff Listed DAI AS are closely associated with board member Øystein Stray Spetalen.



Attachment



EN
30/05/2023

Underlying

VISTNVistin Pharma ASA

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Vistin Pharma ASA

 PRESS RELEASE
Free
VISTN Vistin Pharma A...

Vistin Pharma ASA: Notice of Annual General Meeting 22 May 2025

Vistin Pharma ASA: Notice of Annual General Meeting 22 May 2025 Oslo, Norway, 29 April 2025 Vistin Pharma ASA (OSE: VISTN), please find attached the call for the Annual General Meeting in Vistin Pharma, to be held on 22 May 2025 at 13:00 CEST. A physical Annual General Meeting will not be held. Instead, shareholders should authorize the Chairman of the Board. It is possible to give proxy with and without voting instructions. By using a proxy with voting instructions, the shareholders will vote on the specific issues without personal attendance. For further information on the use of prox...

April 29, 2025 1 EN
 PRESS RELEASE
Free
VISTN Vistin Pharma A...

2024 Annual Report Vistin Pharma ASA

2024 Annual Report Vistin Pharma ASA Oslo, Norway, 25 April 2025 Please find attached the Annual Report for 2024 for Vistin Pharma ASA (VISTN). There are no material changes in the financial statements compared to the preliminary full year results presented on 13 February 2025. The annual report for 2024 will also be made available on . ***** For further information, please contact: Alexander KarlsenCFO   This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.     Attachments ...

April 25, 2025 1 EN
 PRESS RELEASE
Free
VISTN Vistin Pharma A...

Vistin Pharma ASA: First quarter 2025 financial results

Vistin Pharma ASA: First quarter 2025 financial results Oslo, Norway, 25th of April 2025 Vistin Pharma ASA (VISTN) today announces the financial results for the first quarter of 2025. Revenue in the first quarter ended at MNOK 115 compared to MNOK 104 in Q1 2024. Sales volume in the quarter was up by 14% compared to same quarter last year. First quarter EBITDA ended at MNOK 30 compared to MNOK 20 in Q1 2024, an increase of 48%. EBITDA positively affected by increased sales volume and product mix in the quarter, in addition to continues focus on cost improvements. The net profit ended at...

April 25, 2025 1 EN
 PRESS RELEASE
Free
VISTN Vistin Pharma A...

Vistin Pharma ASA: Invitation to Q1 2025 conference call

Vistin Pharma ASA: Invitation to Q1 2025 conference call Oslo, Norway, 15 April 2025 Vistin Pharma ASA (VISTN) will release its first quarter results on Friday 25th of April 2025. Vistin Pharma will host a conference call for all shareholders and interested parties at the same day at 08:30 CET. There will be a Q&A session following the management discussion. The conference call will be held in English. The first quarter conference call will be available via web and audio through the following access points: Webcast: Telephone conference (online registration): ***** For further in...

April 15, 2025 1 EN
 PRESS RELEASE
Free
VISTN Vistin Pharma A...

Vistin Pharma ASA: Key information relating to the proposed cash divid...

Vistin Pharma ASA: Key information relating to the proposed cash dividend The Board of Directors of Vistin Pharma ASA (VISTN) will propose to distribute a cash dividend of total NOK 1.25 per share, to be paid in June, for the accounting year of 2024. The formal decision regarding the dividend will be made on the company's Annual General Meeting, which will be held on 22 May 2025. Dividend amount (per share): NOK 1.25 Declared currency: NOK Last day including right: 3 June 2025 Ex-date: 4 June 2025 Record date: 5 June 2025 Payment date (on or about): 12 June 2025 Date of approval: 2...

February 13, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch